Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
105.00    0.50 (0.48%)
Bid:
104.50
Ask:
107.00
Spread: 2.50 (2.392%)
Market Cap: £306.84m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

Trading Update

22 Jul 2025 07:00

RNS Number : 9351R
Big Technologies PLC
22 July 2025
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Big Technologies plc

("Big Technologies" or "the Company", together with its subsidiaries the "Group")

Trading Update

Big Technologies plc (AIM: BIG), a leading provider of electronic monitoring solutions for criminal justice and remote care, provides the following update for the six months ended 30 June 2025.

Highlights

· Total Group revenues of approximately £24.8m (H1 2024: £26.5m), £26.1m on a constant currency1 basis;

 

· Criminal Justice revenues of approximately £24.5m (H1 2024: £26.2m). Underlying revenue growth of 4% when excluding the Colombia contract;

 

· Other revenues, including Remote Care revenues were flat in the period at £0.3m (H1 2024: £0.3m);

 

· Two new contracts commencing in H2 2025: Northern Ireland Department of Justice and enlarged renewal of Queensland Corrective Services contract;

 

· Adjusted EBITDA2 of approximately £12.5m (H1 2024: £14.3m), which excludes an exceptional foreign exchange loss of £4.0m in relation to US Dollar balances held in anticipation of a potential acquisition; and

 

· Strong balance sheet with net cash of £94.9m.

 

The Group expects to report revenues for the first half of approximately £24.8m (H1 2024: £26.5m). The Group has continued to see a steady increase in demand for its products from Criminal Justice customers with underlying revenue growth of 4% excluding the Colombia contract from H1 2024.

There has been no impact on the Group from US tariffs during the period.

The gross margin remains high at approximately 67.5% (H1 2024: 70%). This represents a small reduction of 0.6% from FY 2024.

Underlying administrative expenses3 were steady with H1 2024 resulting in Adjusted EBITDA of approximately £12.5m in H1 2025 (H1 2024: £14.3m). Adjusted EBITDA excludes an exceptional foreign exchange loss of £4.0m. The Group held a significant cash balance in US Dollars at 31 December 2024 in anticipation of a potential US acquisition in early 2025. With the acquisition not proceeding, the cash has now been repatriated.

The Group retains a robust balance sheet, with net cash increasing from £93.9m at 31 December 2024 to £94.9m at 30 June 2025 (30 June 2024: £92.9m) notwithstanding the impact of the foreign exchange loss on US Dollar balances since repatriated and continuing litigation costs.

BIG expects to release its interim results for the six months ended 30 June 2025 on 30 September 2025.

 

1 Constant currency is calculated by recalculating H1 2025 revenues using prevailing average foreign exchange rates from H1 2024.

2 Adjusted EBITDA excludes share-based payments and adjusting items

3 Underlying administrative expenses excludes share-based payments, adjusting items and the impact of all foreign exchange rate fluctuations

 

 

Ian Johnson, Big Technologies CEO, said:

"Significant progress has been made in establishing a new organisation and management structure to drive growth in our core markets of Criminal Justice and Remote Care. 

The Group remains well-positioned with the financial flexibility to continue to invest in product and market development. The electronic monitoring market continues to experience significant tailwinds, which together with a clear growth strategy and market leading products, places the Group in a strong position to compete for new business globally.

Following the announcement earlier this year regarding the award of the Northern Ireland contract by the Department of Justice, I am delighted to say that the Company is now able to announce that the Group has resecured the Queensland Corrective Services contract. This is a five-year agreement, with the potential for two additional two-year extension periods. The expected total contract value for the initial 5 year period is AUD 22m, and represents an increase of AUD 4.9m from the previous arrangement over the initial period.

I would like to thank our employees, who despite significant disruption during the period, displayed great resilience and continued to maintain momentum in the business. I would also like to thank our shareholders for their continued support and look forward to providing a further update at the time of the Interim results."

 

-Ends-

 

Enquiries

Big Technologies plc

+44 (0) 192 360 1910

Ian Johnson (Chief Executive Officer)

Mike Johns (Chief Financial Officer)

Zeus (Nominated Adviser and Joint Broker)

 +44 (0) 203 829 5000

Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

Singer Capital Markets (Joint Broker)

 +44 (0) 207 496 3000

James Moat / James Todd (Investment Banking)

 

About

Big Technologies is a market leader in the remote personal monitoring industry, operating under the trusted 'Buddi' brand. The Company delivers innovative, high-quality solutions that combine advanced hardware and software to support the monitoring of individuals in both the criminal justice and remote care sectors.

Through its integrated technology platform, Big Technologies offers state-of-the-art Electronic Monitoring solutions on a subscription-based, SaaS-like model. This platform is highly flexible and scalable, enabling tailored deployments across diverse use cases and geographies.

The Company's core technologies are designed to meet the evolving needs of governments, agencies, and care providers, ensuring safety, compliance, and peace of mind through reliable, real-time monitoring.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIRDLILFIE
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
30th Mar 20267:00 amRNSAudited Results for the year to 31 December 2025
26th Feb 20267:00 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBoard Changes
2nd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSFurther Litigation Update
10th Dec 20259:41 amRNSHolding(s) in Company
9th Dec 20259:42 amRNSHolding(s) in Company
8th Dec 20257:00 amRNSTrading Update
3rd Nov 20252:54 pmRNSDirector and PDMR Dealings
16th Oct 20257:01 amRNSWithdrawal of General Meeting Requisition Notice
16th Oct 20257:00 amRNSBoard Changes
3rd Oct 20257:00 amRNSBoard Changes
30th Sep 20257:00 amRNSInterim Results for the 6 months to 30 June 2025
26th Sep 20257:00 amRNSNotice of Requisition of a General Meeting
12th Sep 20257:00 amRNSLitigation Update
20th Aug 20257:00 amRNSChange of Website Address
6th Aug 20257:00 amRNSBoard Change and Issue of Shares
1st Aug 20257:00 amRNSIssue of Shares
28th Jul 20257:00 amRNSBoard Changes
22nd Jul 20257:00 amRNSTrading Update
18th Jun 20252:53 pmRNSResult of AGM and Litigation Update
13th Jun 20258:12 amRNSPublication of Letter to Shareholders
10th Jun 20251:27 pmRNSSuspension of Voting Rights and Letter Response
5th Jun 20257:00 amRNSLitigation Update
22nd May 20259:45 amRNSDirector Dealings
22nd May 20257:00 amRNS2024 Audited Results and Notice of AGM
16th May 20257:00 amRNSAppointment of Joint Corporate Broker
8th May 20257:00 amRNSBoard and Management Changes and Trading Update
7th Apr 20257:00 amRNSAppointment of Non Executive Director
3rd Apr 20257:00 amRNSUpdate re: CEO Dismissal
1st Apr 20257:00 amRNS-RContract Award
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:20 pmRNSCEO Dismissal and Commencement of Litigation
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:13 amRNSLitigation Update
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202512:51 pmRNSCEO Suspension
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.